- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03132506
E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research
E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research Focused on Capture of Patient Reported Outcomes With Within PRAEGNANT Study Network
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Paperbacked pPRO data from up to a total of 100 patients from the cohort of PRAEGNANT are planned to be included in the Pepper I PRO study. Additionally 200 patients will be recruited in the web based ePRO cohort. The study duration per patient is at least 8 weeks. In cases of stable disease the study duration can be extended to up to 6 months with monthly PRO assessments, according to the attached visit matrix, taking approximately 20 minutes per visit.
The documentation at baseline should be performed during clinical routine with trained study personnel followed by remote self-reporting to minimize the patient effort. Pepper I will be conducted as sub-protocol of the PRAEGNANT trial.
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studiekontakt
- Namn: Markus Wallwiener, MD
- Telefonnummer: 0049 6221 56-36956
- E-post: markus.wallwiener@med.uni-heidelberg.de
Studieorter
-
-
-
Tübingen, Tyskland, 72076
- Rekrytering
- Department for Women's Health
-
Kontakt:
- Andreas Hartkopf, Prof. Dr.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Patients enrolled in PRAEGNANT
- Women aged ≥18 years
- Patients with the diagnosis metastasized breast cancer undergoing any form of systemic therapy
- Patients who are willing and able to sign the informed consent form
- Patients with therapy change
Exclusion Criteria:
- Patients who are not eligible for observation due to severe comorbidities or unavailability according to the treating physician
- Patients who are not able to handle a tablet computer or are unable to write
- Patients who are not able to understand the nature and extent of the trial and the procedures require
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Övrig
- Tidsperspektiv: Blivande
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
paper-based patient-reported-outcomes
|
Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes
|
on web-based patient-reported-outcomes
|
Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
QLQ-C30 questionnaire for baseline
Tidsram: 8 weeks
|
Overall patient completion rate in the paperbacked questionnaire and the web-tool, respectively
|
8 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
All other questionnaires for baseline and follow up time points.
Tidsram: Baseline, 8 weeks
|
Overall patient completion rate in the paperbacked questionnaire and the web-tool, respectively,
|
Baseline, 8 weeks
|
Influence factors for the completion rates
Tidsram: 8 weeks
|
age
|
8 weeks
|
Influence factors for the completion rates
Tidsram: 8 weeks
|
line of treatment
|
8 weeks
|
Influence factors for the completion rates
Tidsram: 8 weeks
|
treatment
|
8 weeks
|
Influence factors for the completion rates
Tidsram: 8 weeks
|
technical skills
|
8 weeks
|
Influence factors for the completion rates
Tidsram: 8 weeks
|
patient's satisfaction
|
8 weeks
|
Adverse events-1
Tidsram: 8 weeks
|
The date of clinical diagnosis of AE compared with the date of early AE onset
|
8 weeks
|
Adverse events-2
Tidsram: 8 weeks
|
Consistency of AE documentation ePRO and clinician based
|
8 weeks
|
Patient satisfaction
Tidsram: baseline, 4 weeks, 8 weeks
|
at baseline, after 4 weeks and after 8 weeks
|
baseline, 4 weeks, 8 weeks
|
Health related quality of life (HRQL) assessements -1
Tidsram: baseline, 4 weeks, 8 weeks
|
EORTC QLQ C-30
|
baseline, 4 weeks, 8 weeks
|
Health related quality of life (HRQL) assessements -1
Tidsram: baseline, 4 weeks, 8 weeks
|
BR23
|
baseline, 4 weeks, 8 weeks
|
Health related quality of life (HRQL) assessements -1
Tidsram: baseline, 4 weeks, 8 weeks
|
NCCN distress thermometer,
|
baseline, 4 weeks, 8 weeks
|
Health related quality of life (HRQL) assessements -1
Tidsram: baseline, 4 weeks, 8 weeks
|
EQ-VAS
|
baseline, 4 weeks, 8 weeks
|
Health related quality of life (HRQL) assessements -1
Tidsram: baseline, 4 weeks, 8 weeks
|
PHQ-9
|
baseline, 4 weeks, 8 weeks
|
Health related quality of life (HRQL) assessements -2
Tidsram: baseline, 8 weeks
|
The HRQL assessements EQ-5D-5L measured at baseline and weekly (8 weeks)
|
baseline, 8 weeks
|
Health related quality of life (HRQL) assessements -2
Tidsram: baseline, 8 weeks
|
The HRQL assessements PROCTCAE Endocrine measured at baseline and weekly (8 weeks)
|
baseline, 8 weeks
|
Health related quality of life (HRQL) assessements -2
Tidsram: baseline, 8 weeks
|
The HRQL assessements PROCTCAE taxane measured at baseline and weekly (8 weeks)
|
baseline, 8 weeks
|
Samarbetspartners och utredare
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- PEPPER
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Bröstcancer Metastaserande
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital och andra samarbetspartnersAvslutadDen kliniska tillämpningsguiden för Conebeam Breast CTKina
-
ETOP IBCSG Partners FoundationAvslutadBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAvslutadBreast Cancer Invasive NosSpanien
-
I-Mab Biopharma Co. Ltd.Inte längre tillgängligSolid Tumor Metastatic Cancer Advanced Cancer
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...OkändBRCA1-mutation | Breast Cancer Invasive NosPolen
-
University Health Network, TorontoAvslutadBreast Cancer Invasive Nos | Primär invasiv bröstcancerKanada
-
Novartis PharmaceuticalsAvslutadMetastaserad bröstcancer (MBC) | Locally Advance Breast Cancer (LABC)Storbritannien, Spanien
-
PfizerAvslutadBRAF eller NRAS Mutant Metastatic MelanomFörenta staterna, Nederländerna, Italien, Tyskland, Schweiz
-
McMaster UniversityCanadian Breast Cancer FoundationAvslutadBreast Cancer Invasive Nos | Steg 0 BröstkarcinomKanada
-
Sunnybrook Health Sciences CentrePfizerAvslutadClear Cell Metastatic Renal Cell CarcinomKanada
Kliniska prövningar på patient-reported-outcomes
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Har inte rekryterat ännuDiabetes typ 2Förenta staterna
-
University of Michigan Rogel Cancer CenterAstraZenecaAvslutadKronisk lymfatisk leukemi | Kronisk myeloid leukemi | Flera kroniska tillståndFörenta staterna
-
University Hospital, Basel, SwitzerlandAvslutadSkada på främre korsbandet (ACL)Schweiz
-
Medizinische Hochschule Brandenburg Theodor FontaneUniversity of JenaRekrytering
-
Taipei Veterans General Hospital, TaiwanRekryteringSystemisk lupus erythematosus | Torra ögon syndrom | Sjögrens syndromTaiwan
-
Centre for Evidence-Based Practice, BelgiumBelgian Red CrossAvslutadStroke | BrännskadorBelgien
-
CorinRekryteringOsteo Artrit Knä | Total knäprotesplastik | Totalt knäbyte | KnäsjukdomFrankrike
-
Eva KlappeAvslutadKvaliteten på hälso- och sjukvården | Människor | Kliniskt beslutsfattande | Evidensbaserad praktik | Beslutsfattande, datorstödd | Medicinska journaler, problemorienterad | Datanoggrannhet | Dokumentation / Standarder | Dokumentation / Statistik & numeriska data | Formulär och registerkontroll / standarder | Internationell klassificering av sjukdomar/standarderNederländerna
-
Hospital Universitario Reina Sofia de CordobaSpanish Society of Family and Community MedicineAvslutadFörmaksflimmer